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Abstract
Background: Cysteine (Cys) and its disulfide, cystine (CySS) represent the major extracellular thiol/disulfide redox control
system. The redox potential (Eh) of Cys/CySS is centered at approximately 280 mV in the plasma of healthy adults, and
oxidation of Eh Cys/CySS is implicated in inflammation associated with various diseases.
Methodology/Principal Findings: The purpose of the present study was to determine whether oxidized Eh Cys/CySS is a
determinant of interleukin (IL)-1b levels. Results showed a 1.7-fold increase in secreted pro-IL-1b levels in U937 monocytes
exposed to oxidized Eh Cys/CySS (246 mV), compared to controls exposed to a physiological Eh of 280 mV (P,0.01). In
LPS-challenged mice, preservation of plasma Eh Cys/CySS from oxidation by dietary sulfur amino acid (SAA)
supplementation, was associated with a 1.6-fold decrease in plasma IL-1b compared to control mice fed an isonitrogenous
SAA-adequate diet (P,0.01). Analysis of Eh Cys/CySS and IL-1b in human plasma revealed a significant positive association
between oxidized Eh Cys/CySS and IL-1b after controlling for age, gender, and BMI (P,0.001).
Conclusions/Significance: These data show that oxidized extracellular Eh Cys/CySS is a determinant of IL-1b levels, and
suggest that strategies to preserve Eh Cys/CySS may represent a means to control IL-1b in inflammatory disease states.
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Introduction
Interleukin (IL)-1b is a pro-inflammatory cytokine that functions
as a critical regulator of host defense in response to infection and
injury. However when present in excess, IL-1b is extremely toxic
[1]. Elevated systemic levels of IL-1b cause hypotension during
septic shock and induce capillary leak in acute lung injury [2]. IL-
1b is also involved in chronic inflammation associated with
arthritis, lung fibrosis, and atherosclerosis [3,4,5]. Therefore,
strategies to modulate IL-1b production in inflammatory diseases
are of therapeutic interest.
IL-1b activation and induction are associated with inflamma-
tion, a process with enhanced generation of reactive oxygen and
nitrogen species [6]. These reactive species serve multiple
biological functions, which include removal of cell debris and cell
signaling necessary for host defense. Recent advances in redox
signaling mechanisms have revealed that functional pathways
utilize diffusible oxidants such as peroxide and redox-sensitive
thiols in specific proteins as sensors [7]. The redox states of these
sensors are controlled by rates of oxidation of specific amino acid
residues and their reduction by thiol/disulfide control systems.
The thiol/disulfide control systems are compartmentalized;
glutathione/glutathione disulfide (GSH/GSSG) and thioredoxin
provide control mechanisms within cells, while cysteine/cystine
(Cys/CySS) and GSH/GSSG control the redox state of proteins
in the extracellular space and on the cell surface [8]. The Cys/
CySS couple predominates in the extracellular fluid and the
steady-state redox potential (Eh) of Cys/CySS is oxidized in acute
and chronic inflammatory disease states [9]. In vitro, oxidized Eh
Cys/CySS induces upregulation of nuclear factor-kappa B (NF-
kB) [10,11], increases adhesion of leukocytes to the endothelium
[10], and sensitizes epithelial cells to apoptosis [12]. Based on these
observations, we hypothesized that extracellular Eh Cys/CySS is a
determinant of pro-inflammatory cytokine production.
We tested this hypothesis by modifying extracellular Eh Cys/
CySS and determining IL-1b levels in vitro and in vivo. In vitro results
showed that oxidized extracellular Eh Cys/CySS is sufficient to
increase pro-IL-1b levels in monocytes, and in vivo results showed
that dietary treatment to protect against plasma Eh Cys/CySS
oxidation is associated with decreased IL-1b levels in LPS-
challenged mice. Analysis of Eh Cys/CySS and IL-1b in human
plasma revealed a significant positive association between oxidized
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e5017Eh Cys/CySS and IL-1b, independent of age, gender, and BMI.
Together, the data show that oxidized extracellular Eh Cys/CySS
is one of the determinants of IL-1b levels, and suggest that
strategies to preserve Eh Cys/CySS may represent a means to
control IL-1b in inflammatory disease states.
Materials and Methods
Ethics Statement
All protocols involving human subjects were reviewed and
approved by the Emory Institutional Review Board. All protocols
involving mice were reviewed and approved by the Institutional
Animal Care and Use Committee at Emory University.
Materials
Except as indicated, all chemicals were purchased from Sigma
Chemical Corporation (Sigma, St. Louis, MO). Distilled, deion-
ized water was used for analytical purposes. HPLC quality solvents
were used for HPLC.
Cell culture
Human monocytic cells (U937, ATCC, Rockville, MD) were
maintained in RPMI-1640 supplemented with 10% fetal bovine
serum (FBS, Atlanta Biologicals, Norcross, GA) and 10 U/ml
penicillin and streptomycin sulfate. Cells were transferred to 0.5%
FBS media 8–12 h prior to experimental manipulations.
To generate the desired range of extracellular redox potentials,
the extracellular thiol/disulfide pool was altered by varying
concentrations of Cys and CySS, added to cyst(e)ine-free RPMI,
as previously described [11]. In these experiments, the total
extracellular pool size of Cys+CySS was set at 200 mM, while
concentrations of Cys and CySS were varied to obtain initial Eh
values from 280 mV (physiological) to 246 mV (oxidized). The
measured Cys/CySS redox range in human plasma is 2120 to
220 mV [13]. Eh Cys/CySS is centered at 280 mV in healthy
individuals and becomes oxidized with age, lifestyle factors such as
smoking and alcohol abuse [14,15], and pathologies such as atrial
fibrillation [16], and age-related macular degeneration [9].
Therefore, the experimental range of 280 to 246 mV covers
the physiological range and extends to oxidizing values that are
reachable under pathological conditions.
Production of reactive oxygen species (ROS) was detected using
6-Carboxy-29,79-dichlorofluorescein diacetate (DCFH-DA, Mo-
lecular Probes, Eugene, OR, USA) [10]. U937 cells, plated into
96-well plate, were washed with KRH buffer and incubated with
100 mM DCFH-DA for 30 minutes (37uC, 5% CO2). Cells were
washed and exposed to physiological (280 mV) and oxidized
(246 mV) Cys/CySS redox media at 37uC. Oxidation of DCFH-
DA to fluorescent DCF was measured on a microplate reader
(excitation, 485 nm; emission, 530 nm) [17].
Experimental animals and dietary intervention
Experiments were conducted using 10–14 week old, female
C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME). Mice
were housed in cages and maintained on a 12-h light-12-h dark
cycle at the Division of Animal Resources at Emory University. All
experiments were initiated during the light cycle. All animal
protocols were reviewed and approved by the Institutional Animal
Care and Use Committee.
Prior to the dietary intervention, all animals were fed pelleted
rodent food (Test Diet 5015, Lab Diet Inc., Richmond, IN). Semi-
purified diets were custom-prepared (Harlan-Teklad, Madison,
WI, USA) in order to test the specific effects of sulfur amino acid
(SAA) supplementation [18]. The SAA-adequate and SAA-
supplemented diets were isocaloric and isonitrogenous and
contained adequate and identical quantities of energy, nitrogen,
carbohydrate, fat, fiber, micronutrients and essential amino acids.
The SAA and nitrogen content was controlled at the desired
experimental levels by varying the amount of cystine and
methionine and the non-essential amino acids L-alanine, L-
aspartic acid, glycine and L-serine. The SAA-supplemented diet
contained 3-fold cystine, and 1.8-fold methionine compared to the
SAA-adequate diet. Animals had free access to water at all
experimental time points.
LPS Administration
Escherichia coli O55:B5 LPS, dissolved in sterile PBS (100 mg/ml)
was administered intraperitoneally to unanaesthetized animals at a
dose of 1 mg LPS/kg body weight. Animals were sacrificed at 2 h
post-LPS. The dose of LPS was used based on previous
observations that it substantially increases plasma and lung IL-
1b levels [19], and oxidizes plasma Eh Cys/CySS at 2 h [20].
Sample collection and analysis of Cys, CySS, GSH and
GSSG
Mice were anesthetized by isofluorane inhalation (Baxter
Pharmaceuticals, Deerfield, IL). Opening of the blood brain
barrier is reported at high concentrations of isoflurane [21]. The
implications of this deleterious effect of isoflurane to measurements
made in the current study are presently unknown. Subsequent to
anesthesia, blood was collected by submandibular bleeding using a
4 mm mouse bleeding lancet (Medipoint, Inc. Mineola, NY).
0.18 ml of collected blood was immediately transferred to 0.02 ml
of preservation solution containing c-glutamyl-glutamate (c-Glu-
Glu) as an internal standard [22].
Samples were centrifuged at 16000 g for 60 seconds to remove
precipitated protein, and 0.1 ml of the supernatant was immedi-
ately transferred to an equal volume of ice-cold 10% (w/v)
perchloric acid. Samples were immediately stored at 280uC.
For HPLC analysis (Gilson Medical Electronics, Middleton,
WI), derivatized samples were centrifuged, and 50 ml of the
aqueous layer was applied to the Supercosil LC-NH2 column
(25 cm64.6 mm; Supelco, Bellefunk, PA). Derivatives were
separated with a sodium acetate gradient in methanol/water
and detected by fluorescence [23]. Concentrations of thiols and
disulfides were determined by integration relative to the internal
standard. Redox potential s (Eh) of the GSH/GSSG and Cys/
CySS pools, given in millivolts (mV), were calculated from
concentrations of GSH, GSSG and Cys, CySS in molar units
with the following forms of the Nernst equation for pH 7.4: GSH/
GSSG, Eh=2264+30 log ([GSSG]/[GSH]
2), Cys/CySS,
Eh=2250+30 log ([CySS]/[Cys]
2)[24].
Quantitative Real-Time PCR Analysis
Lung samples were excised, snap frozen in liquid N2 and stored
at 280uC. Total RNA was extracted from tissue using an RNeasy
Midi Kit (QIAGEN Inc., Valencia, CA) according to manufac-
turer’s instructions. DNase treatment was performed to remove
contaminating genomic DNA. RNA concentration was spectro-
photometrically determined at 260 nm, and 0.5 mg of total RNA
was used to synthesize 20 ml of cDNA (Invitrogen, Carlsbad, CA).
Quantitative real-time PCR was performed on cDNA using gene-
specific primers on an iCycler IQ Real-Time PCR Detection
System (Bio-Rad Laboratories, Hercules, CA). Primers were
designed using Beacon Designer Software 4.00 (PREMIER Biosoft
International, Palo Alto, CA) (Table 1). Samples containing serial
dilutions of known concentrations of cDNA, encoding the gene of
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iCycler Software, and starting quantities of message levels of each
gene were determined from constructed standard curves. Melt
curves were examined to ensure amplification of a single PCR
product. Expression level of IL-1b was normalized to b-actin in
monocytes and 18S ribosomal RNA in mouse lung tissue.
Cytokine and Western blot analysis
Levels of IL-1b in the cell-supernatant were detected by ELISA
(R&D Systems, Minneapolis, MN), and are expressed relative to
total protein content in the supernatant. Western Blot analysis of
the cell extract from U937 cells was performed to detect the
precursor form of IL-1b. After washing with PBS, cells were lysed
in homogenization buffer (50 mM NaCl, 50 mM NaF, 50 mM
NaP207-10 H20, 5 mM EDTA, 5 mM EGTA, 2 mM Na3 V04,
0.5 mM PMSF, 0.01% Triton X-100, 10 ug/ml leupeptin,
10 mM HEPES, pH 7.4) and the concentration of proteins was
determined by using a Bradford reagent (Bio-Rad, Hercules, CA).
Equal amounts of protein were loaded onto 10% acrylamide
SDS/PAGE gradient gels (Bio-Rad).
Proteins were transferred onto nitrocellulose membranes using a
semi-dry trans-blot apparatus set at 25 V for 1 h (Bio-Rad).
Membranes were subsequently incubated overnight with an anti-
human IL-1b polyclonal antibody (Cell Signaling Technology,
Danvers MA). Rabbit polyclonal anti-b-actin (Abcam Cambridge,
MA) was used as a loading control. After washing with tris
buffered saline (TBS) (10 mM Tris-HCL, pH 8.0, 150 mM NaCl,
0.05% Tween-20), membranes were incubated for about 1 h at
room temperature with goat anti-rabbit IgG conjugated to
horseradish peroxidase-coupled secondary antibody. After further
washing, immunoreactive signals were determined by chemilumi-
nescence. Protein bands were quantified by densitometric
scanning using a GS-800 Calibrated laser densitometer (Bio-Rad).
To better assess the inflammatory status in vivo, levels of IL-1b,
and tumornecrosisfactor(TNF)-a were measured. IL-1b and TNF-
a in human plasma, mouse plasma, and mouse lung homogenates
were detected by immunofluorescence using a multiplex panel assay
(R&D Systems, Minneapolis, MN). Briefly, the antibody coupled
beads wereincubatedwith thesample followed byincubationwith a
detection antibody. Fluorescence intensity was read on a Bioplex
suspension array system (Bio-Rad, Hercules, CA).
IL-1b luciferase reporter assay
To evaluate IL-1b gene transcription, U937 monocytes were
electroporated with a pIL-1 (4.0 kb) luciferase promoter construct,
as previously described [25]. Cells were plated in 6-well plate and
were incubated for 8 h in specific redox media. Cells were lysed in
reporter lysis buffer (Promega, Madison, WI) and assayed for
luciferase activity. Measurements were done using a Labsystems
Luminoskan Ascent Plate Luminometer. Results were recorded as
luciferase units and were adjusted for total protein content.
Human subjects
This study was reviewed and approved by the Emory
Institutional Review Board. A total of 16 healthy volunteers were
recruited by posting fliers in public locations in the Atlanta/Emory
University community. Following written informed consent,
participants were admitted to the outpatient unit of the Emory
University Hospital General Clinical Research Center (GCRC),
where potential subjects were screened using a medical history,
physical examination, urinalysis, standard chemistry profile and a
complete blood count. Eligibility was established based on the
following criterion: absence of acute or chronic illness (other than a
medical history of well-controlled hypertension), BMI,30, non-
smokers, and compliance in discontinuing nutritional supplements,
if consumed, 2 weeks prior to study entry. Eligible participants
were then scheduled for a 24 h inpatient visit within 2 weeks of
screening in the GCRC. Characteristics of study subjects are
presented in Table 2.
Human study protocol
Participants were instructed not to eat after 10 pm the night
prior to the inpatient visit in order to standardize baseline levels of
metabolites. Participants were admitted to the GCRC at 7.00 on
Day 1 and a heparin-lock catheter was placed in a forearm vein for
blood sampling at 8.00. After a 30-minute supine resting period,
3 ml blood samples were drawn every hour for 24 consecutive
hours. Participants were given breakfast at 9:30, lunch at 13:30,
dinner at 17:30, an evening snack was provided at 21:30
immediately following the timed blood draw for that hour. The
composition of the meals and snack was standardized for all
Table 1. Details of PCR primer sequences used in the analyses of extracted RNA for quantitative real-time PCR.
Target
Genbank accession
number Forward primer Reverse primer
Product
size, bp
IL-1b human NM_000576 TGATGGCTTATTACAGTGGCAATG GTAGTGGTGGTCGGAGATTCG 140
b-actin human NM_001101 GCGTGACATTAAGGAGAAG GAAGGAAGGCTGGAAGAG 172
IL-1b mouse NM_008361 ATCTCGCAGCAGCACATC CAGCAGGTTATCATCATCATC 192
18S mouse NR_003278 CGTCTGCCCTATCAACTTTCG GCCTGCTGCCTTCCTTGG 130
doi:10.1371/journal.pone.0005017.t001
Table 2. Characteristics of study subjects.
Demographics
Age, mean+SD 60.3+17.9
BMI, mean+SD, kg/m
2 24.2+3.1
Females, % 56
Fasting markers, mean+SD
Cys, mM9 . 2 +2.8
CySS, mM 66.6+13.9
EhCys/CySS, mV (2)71.7+9.2
GSH, mM1 . 2 +0.4
GSSG, mM 0.07+0.02
EhGSH/GSSG, mV (2)122.8+9
TNF-a, pg/mL 4.5+3.7
IL-1b, pg/mL 3.6+3.6
doi:10.1371/journal.pone.0005017.t002
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throughout the study period.
Statistical Methods
Data are presented as means+SEM. Statistical analysis was
done using SAS v 9.1 (SAS Institute Inc., Cary, NC, US). Data
from in vitro experiments were analyzed using an unpaired t-test.
Data from in vivo murine experiments were analyzed using a one-
way ANOVA with treatment specified as the main effect. To
analyze data from human plasma, a linear mixed model was used.
The association of Cys, CySS, and Eh Cys/CySS with IL-1b, and
TNF-a was determined after controlling for time of day, BMI, age,
and gender. Because none of the potential confounders had
statistically significant regression coefficients, parameters for BMI,
age, and gender were excluded to arrive at the most parsimonious
model. The residuals for thiol/disulfide redox were normally
distributed; therefore thiol/disulfide redox was specified as the
response variable in all constructed models to improve the stability
of the computed regression coefficients. The human study by its
very design cannot establish a cause-effect relationship; causality is
therefore not invoked by specification of thiol/disulfide redox as
dependent and cytokine as the independent variable. The best
model from all subsets was determined using the Akaike
Information Criterion (AIC). Significance was set at a P value
,0.05 for all tests.
Results
Oxidized extracellular Eh Cys/CySS increases pro-IL-1b
and IL-1b mRNA levels in human monocytes
Measurements of Cys and CySS in human plasma show that Eh
Cys/CySS is centered at approximately 280 mV in healthy young
individuals [24] and is oxidized in association with inflammatory
disease states [9]. In vitro, oxidized extracellular Eh Cys/CySS
activates nuclear factor (NF)-KB, a key pro-inflammatory
transcription factor [10,11]. Together, these data indicate that
oxidized Eh Cys/CySS is likely to modulate pro-inflammatory
cytokine production. Because peripheral blood monocytes are
constantly exposed to the extracellular redox environment, we
determined whether levels of IL-1b, a major monocyte-derived
cytokine, are increased by oxidized extracellular Eh Cys/CySS.
U937 monocyteswere exposedto Eh of 280 mV(physiological) or
246 mV (oxidized) for 8 h and levels of IL-1b were determined in
the cell extract by western blot using an antibody that detects both the
precursor and matureformsof IL-1b. Figure 1A shows an increase in
cellular levels of the IL-1b precursor at 246 mV compared to
280 mV (lane 1 versus lane 3; P,0.05). IL-1b levels were also
determined in cells treated with LPS (100 mg/ml) under different
redox conditions, to assess whether IL-1b is increased in oxidized
extracellular Eh under inflammatory states. The data show increased
cellular levels of the IL-1b precursor at 246 mV compared to
280 mV with LPS treatment (lane 2 versus lane 4; P,0.05).
Because an increase in the precursor form of IL-1b was
observed in the cell extract under oxidized conditions, we next
attempted to quantify secreted IL-1b levels in the cell-supernatant
by ELISA. In monocytes and macrophages, the release of mature
IL-1b is dependent on stimulation of caspase-1 by extracellular
ATP [27]. Because ATP was not added to the media, the form of
IL-1b measured by ELISA is likely the precursor form. Figure 1B
shows a 1.7-fold increase in precursor form of IL-1b in cells treated
with Eh of 246 mV compared to 280 mV (P,0.01).
To determine whether increased pro-IL-1b in response to
oxidized Eh occurred due to increase in mRNA abundance, IL-1b
mRNA was quantified by real-time PCR. As shown in Figure 1C,
IL-1b mRNA was more abundant in response to Eh of 246 mV,
4 h after treatment (P,0.05). Experiments with U937 cells
expressing the human IL-1b promoter fused to a luciferase
reporter gene revealed significant increase in luciferase activity at
246 mV, suggesting transcriptional induction of IL-1b by
oxidized Eh (Figure 1D; P,0.05).
Oxidized extracellular Eh Cys/CySS induces intracellular
ROS production in monocytes but has no effect on
cellular Eh GSH/GSSG
Previous studies have shown that induction of IL-1b by
extracellular stimuli, such as ATP, is associated with generation
of ROS and up-regulation of genes involved in GSH synthesis
[27]. Therefore, we determined whether increase in IL-1b in
response to oxidized extracellular Eh Cys/CySS is associated with
intracellular redox changes. Measurement of cellular GSH
(Figure 2A) and Eh GSH/GSSG (Figure 2B) revealed no
significant differences between the 280 and 246 mV treatment
groups at 2 h and 8 h.
Next, we examined whether oxidized extracellular Eh Cys/
CySS stimulated cellular ROS production. Cells were pre-
incubated with a ROS-sensitive dye, DCFH-DA, prior to
treatment with 280 mV and 246 mV Cys/CySS redox media.
Oxidation of DCFH-DA to fluorescent DCF was measured on a
microplate reader. Cells treated with glucose oxidase served as
positive controls. Within 5 minutes, cells exposed to oxidized Eh of
246 mV showed a 5-fold increase in DCF fluorescence compared
to cells exposed to a physiological redox potential of 280 mV
(P,0.001) (Figure 2C). When measured 2–6 h after treatment, the
magnitude of DCF fluorescence increased in both 280 and
246 mV conditions, with at least a 2-fold higher fluorescence at
246 mV (P,0.001, data not shown). This indicates that oxidized
Eh-induced ROS production was sustained over-time, and
occurred in the absence of oxidation to cellular Eh GSH/GSSG.
We subsequently determined whether increase in ROS, in
response to oxidized extracellular Eh Cys/CySS, was sensitive to
the oxidation of redox-sensitive membrane-bound thiols. To this
end, monocytes were pre-treated with 0.25 mM 4-acetamide-49-
amleimidylstilbene-2,29-disulfonic acid (AMS), a non-permeant
alkylating agent, prior to exposing the cells to given Eh Cys/CySS.
Pre-treatment with AMS decreased (P,0.001), but did not
completely inhibit, cellular ROS levels in response to oxidized
Eh indicating that increase in cellular ROS occurs in part due to
oxidation of membrane-bound thiols [10].
Taken together the in vitro data show that oxidized extracellular
Eh Cys/CySS induces a rapid and sustained increase in ROS in
monocytes compared to physiological Eh, which could be involved
in oxidized Eh mediated increase in IL-1b. Based on these in vitro
findings, we wanted to determine whether increase in IL-1b
during inflammation in vivo can be attenuated by preservation of
Eh Cys/CySS from oxidation.
Dietary SAA supplementation protects against
endotoxin-induced perturbations in plasma Cys, CySS
and Eh Cys/CySS
Based on previous research showing that supplementation with
sulfur amino acids (SAA) increases plasma Cys and shifts the Eh to
a more reduced potential [18], we applied this approach to a
mouse model of inflammation in which LPS/endotoxin is
administered to increase IL-1b [19]. In this design, mice were
fed either a SAA-adequate diet or an isonitrogenous SAA-
supplemented diet for 7 days prior to endotoxin challenge. Mice
were sacrificed 2 h post-endotoxin, a time point that coincides
Cysteine Redox in Inflammation
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to sacrifice for analysis of Cys, CySS, GSH and GSSG by HPLC.
Thiol/disulfide redox parameters in untreated controls, fed
pelleted rodent chow, are shown for comparison. Redox potential
values for GSH and Cys are approximately 10–15 mV more
reduced in mice plasma compared to human plasma.
SAA-supplementation protected against endotoxin-induced
decrease in plasma Cys (Figure 3A; Cys (mM) - SAA supplement-
ed, 19.661.9; SAA-adequate, 13.561.2; P,0.05). The decrease in
plasma Cys in response to endotoxin is likely due to clearance of
Cys, and oxidation of Cys to CySS. Ex vivo studies in hepatic
membrane vesicles show that LPS stimulates hepatic influx of Cys
to support gluconeogenesis and synthesis of acute phase proteins
[28]. LPS also increases peroxide levels [29], and this could
decrease plasma Cys via oxidation to CySS, an interpretation
supported by the increase in plasma CySS levels in mice fed SAA-
adequate diet (Figure 3B). However, because the magnitude of
increase in CySS exceeds the decrease in Cys, mechanisms related
to altered transport or recycling of Cys and/or CySS may also
contribute to alterations in Cys/CySS homeostasis during
endotoxemia.
The difference in plasma Cys between SAA-supplemented and
SAA-adequate group is consistent with the predicted increase in
Cys due to excess SAA intake, based on previous work done in our
laboratory [18]. However, plasma CySS levels were not affected
by excess SAA intake [18]. Thus, the lack of increase in plasma
CySS in the SAA-supplemented group, 2 h post endotoxin,
suggests additional effects on ROS homeostasis due to SAA
supplementation (CySS (mM) - SAA-adequate, 14169.7; SAA
supplemented, 85.261.2; P,0.01). As a consequence of the higher
Cys and decreased CySS, Eh Cys/CySS was on average 15 mV
more reduced in response to endotoxin in the SAA-supplemented
group compared to SAA-adequate group (Figure 3C; SAA-
adequate, 276.462.6; SAA supplemented, 291.563.7; P,0.01).
Figure 1. Oxidized extracellular Eh Cys/CySS increases pro-IL-1b in monocytes. U937 cells were exposed to physiological (280 mV) and
oxidized (246 mV) Eh Cys/CySS for 8 h and levels of the IL-1b precursor were determined by Western blot (A). Western blot analysis of the cell extract
revealed increase in the 31 kDa precursor form of IL-1b at 246 mV compared to –80 mV. Quantitative analysis of the band densities of three separate
experiments is shown as a bar graph. In (B) IL-1b levels determined by ELISA are expressed relative to protein concentration in the cell-supernatant. In
(C), total RNA was extracted 4 h after treatment with redox media. Abundance of IL-1b mRNA was detected by real-time PCR and is normalized to b
actin. In (D), U937 cells expressing the IL-1b-luciferase construct were exposed to given Eh for 12 h. Luciferase activity in cell-lysates is shown after
normalization for total protein. Data are mean+SE of 3 replicates of a representative experiment repeated 3 times, * P,0.05 between 280 mV and
246 mV treatments.
doi:10.1371/journal.pone.0005017.g001
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revealed that plasma Eh GSH/GSSG (Figure 3D) was not
oxidized after endotoxin treatment, and was comparable across
treatment groups. These results confirm that the in vivo model is
adequate to test whether attenuating oxidation of plasma Eh Cys/
CySS decreases plasma IL-1b levels in inflammation.
Dietary SAA supplementation protects against
endotoxin-induced IL-1b and TNF-a
Next, we determined whether the more reducing plasma Eh
Cys/CySS, in SAA-supplemented animals is associated with a
decrease in plasma IL-1b, in response to endotoxin. Plasma IL-1b
levels in untreated controls were un-detectable (not shown). As
shown in Figure 4A, plasma IL-1b decreased by 1.6-fold in SAA-
supplemented animals (IL-1b (pg/ml) - SAA adequate, 190622;
SAA supplemented, 116612; P,0.01). Induction of IL-1b in the
lung is an early response to endotoxin [20], so we determined
whether a protective effect on IL-1b was also observed in the lung,
in response to a reduced extracellular Eh Cys/CySS. Lung IL-1b
levels were decreased by 2-fold in the lung homogenate from the
SAA-supplemented group (Figure 4B; P,0.001). Measurements of
IL-1b message levels by quantitative real-time PCR revealed a 3-
fold decrease in lung IL-1b mRNA levels (Figure 4C; P,0.05).
Thus, preserving extracellular Eh Cys/CySS during endotoxemia
decreased tissue and circulating levels of IL-1b.
Tumor necrosis factor (TNF)-a is another prototypical pro-
inflammatory cytokine that is induced in concert with IL-1b in
response to infection, injury, and immunological challenge [30].
To better assess the inflammatory status in vivo, we determined
whether attenuation of TNF-a also occurred in SAA-supplement-
ed mice. Results showed a greater than 2-fold decrease in plasma
TNF-a levels with SAA-supplementation (Figure 4D; P,0.05).
TNF-a in the lung was also significantly decreased (Figure 4E;
P,0.05). Thus, the in vivo observations show that preservation of
plasma Eh Cys/CySS during endotoxemia is associated with a
decrease in IL-1b levels. These data extend the in vitro
observations, and the combined findings support a mechanistic
role for Cys redox potential in determining IL-1b levels.
IL-1b and TNF-a in plasma of healthy adults are increased
in association with oxidized Eh Cys/CySS
To investigate whether Cys redox potential could represent a
determinant of pro-inflammatory cytokine levels in humans, we
examined IL-1b, TNF-a, Cys, and CySS in plasma samples from
16 healthy adults. The characteristics of the study participants are
shown in Table 2.
Because plasma Cys and Eh Cys/CySS, and cytokines exhibit
well documented circadian rhythms [26,31], the study was
designed to examine whether diurnal variation in Eh Cys/CySS
was associated with variation in IL-1b and TNF-a. For this
purpose, hourly samples were collected for an entire 24 h period
from 16 individuals. Diurnal variation in plasma Cys and Eh Cys/
CySS was closely related to meal intake, as reported previously
(data not shown) [26]. However, due to considerable inter-
individual variation in plasma IL-1b and TNF-a, we did not detect
significant time-dependent variations in cytokine levels. Therefore,
we used a secondary analysis to determine whether variation in Eh
Cys/CySS correlated with variation in IL-1b, independent of time
of day.
Because repeated measures were obtained from the same
individual, we used a linear mixed procedure to model variation in
redox parameters with cytokine levels controlling for time of day,
BMI, age, and gender. As none of the potential confounders had
Figure 2. Oxidized extracellular Eh Cys/CySS induces ROS
production in monocytes but has no effect on cellular Eh GSH/
GSSG. U937 cells were lysed 2 h and 8 h after exposure to 280 mV
and 246 mV Cys redox states. Cellular concentrations of GSH and GSSG
were determined by HPLC. GSH levels (A) and Eh GSH/GSSG (B) were not
significantly different between 80 mV and 246 mV treatments. In (C),
U937 cells were pre-incubated with an ROS-sensitive dye, DCFH-DA
(100 mM) for 30 min, before treating with 280 mV and 246 mV redox
media for 5 min at 37uC. Oxidation of DCFH-DA to fluorescent DCF was
measured on a microplate reader. Cells exposed to oxidized Cys/CySS
redox (246 mV) show a 5-fold increase in ROS production compared to
cells exposed to a physiological redox potential of 280 mV (*P,0.001).
Pre-treating cells with 0.25 mM 4-acetamide-49-amleimidylstilbene-2,29-
disulfonic acid (AMS), a non-permeant alkylating agent, attenuated the
increase in ROS production (P,0.001). As a positive control, ROS
production was measured in monocytes treated with glucose oxidase (2
units); an enzyme system that generates H202 (*P,0.001). NAC pre-
treatment attenuated glucose oxidase-induced ROS production
(*P,0.001). Data are mean+SE of 4 replicates of a representative
experiment repeated 3 times.
doi:10.1371/journal.pone.0005017.g002
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age, and gender were excluded to arrive at the most parsimonious
model. Cys, CySS and Eh Cys/CySS were specified as response
variables in the analyses because the residuals for these biomarkers
were normally distributed. Regression coefficients for the mixed
model are presented in Table 3.
Examination of redox parameters for Cys redox potential
revealed a strong positive association between Eh Cys/CySS and
IL-1b (P,0.001). As seen in Figure 5A, oxidized values of Eh Cys/
CySS correlate with higher levels of plasma IL-1b. The regression
parameter for IL-1b indicates that a 1 unit increase in plasma IL-
1b is associated with a 1.1 mV oxidation of plasma Eh Cys/CySS.
Analysis of the association between plasma Cys and IL-1b revealed
a significant negative association indicating that low levels of
plasma Cys correlate with high IL-1b levels (Figure 5B; P,0.05).
No significant correlation was observed between plasma CySS and
IL-1b. While an association does not establish causality, together
with our in vitro and in vivo data the present findings strongly
suggest that Cys redox potential is an important determinant of
IL-1b. Plasma TNF-a was also significantly associated with Eh
Cys/CySS (Figure 5C) and CySS levels (Figure 5D) (P,0.05)
suggesting that oxidized Cys redox potential is also a determinant
of TNF-a. It must be noted that a caveat that may limit
extrapolation of the results to the general population is the age (62
years) and the BMI (24 kg/m
2) of the population studied. Because
old age and overweight are risk factors for inflammation [32,33],
the association between Eh Cys/CySS and IL-1b and TNF-a may
be less-strong in a younger population with an optimum BMI
range.
Discussion
The current study has three main findings: that oxidized
extracellular Eh Cys/CySS is sufficient to induce pro-IL-1b in a
monocyte cell line; that preservation of plasma Eh Cys/CySS from
oxidation during endotoxin-induced inflammation is associated
with a decrease in circulating IL-1b levels in mice; and that
oxidized Eh Cys/CySS is positively associated with circulating IL-
1b levels in healthy humans. Together, these data suggest that
plasma Cys redox potential is not only a biomarker of oxidative
stress, but may also be a determinant of immune cell function.
Because a number of dietary and behavioral risk factors for disease
are known to oxidize Cys redox potential e.g., sulfur amino acid
deficiency [18], alcohol [34], and smoking [14]; this provides a
mechanistic basis to consider monitoring Cys redox potential as a
risk factor for pro-inflammatory states, and consider interventional
strategies to control oxidation of Cys redox potential in pro-
inflammatory diseases.
Previous studies have shown that induction of IL-1b by non-
infectious extracellular stimuli, such as ATP and cigarette smoke
condensate, occurs by activation of membrane-bound receptors
[27,35]. The mechanism by which oxidized extracellular Eh Cys/
CySS induces pro-IL-1b is unknown, but likely involves the
Figure 3. Effect of dietary SAA-supplementation on endotoxin-
induced oxidation of plasma Eh Cys/CySS. C57BL/6J mice
receiving either SAA-adequate diet or SAA-supplemented diet were
treated with 1 mg/kg i.p endotoxin/LPS. At 2 h, mice were sacrificed
and plasma was collected for HPLC analysis of Cys (A), CySS (B). In (C), Eh
Cys/CySS was calculated from Cys and CySS concentrations using the
Nernst equation. Plasma Eh GSH/GSSG is shown in (D). Data are
mean+SE of 4 replicates of a representative experiment repeated 2
times. 6Values significantly different from untreated controls, *Values
significantly different from SAA-adequate group.
doi:10.1371/journal.pone.0005017.g003
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membrane-bound thiols. Studies in endothelial cells have revealed
increased oxidation of cell-surface protein thiols, induction of
intracellular ROS, and activation of NF-KB in response to an
oxidizing extracellular Eh Cys/CySS [10]. The rapid and
sustained induction of cellular ROS by oxidized Eh in the present
study is consistent with the same type of mechanism in U937 cells,
i.e., the increase in IL-1b by oxidized Eh could be signaled via the
membrane and involve ROS-dependent activation of pro-
inflammatory transcription factors such as NF-KB. Interestingly,
the increase in ROS by oxidized Eh occurred in the absence of
changes to intracellular Eh GSH/GSSG. This observation is,
however, not unexpected. The major thiol/disulfide control
systems GSH, thioredoxin, and Cys exist under non-equilibrium
conditions and their redox states are distinctly modified by
oxidative stress [14], substrate availability [18,36,37], physiological
[26] and pathological stimuli [8,36]. Indeed, the present research
shows that the oxidation of plasma Eh Cys/CySS during acute
endotoxemia in vivo occurs without the oxidation of plasma Eh
GSH/GSSG.
The acute oxidation of Eh Cys/CySS by LPS is attenuated in
mice supplemented with sulfur amino acids (SAA). This effect
could be solely due to dietary augmentation of Cys reserves, an
interpretation supported by the 1.4-fold higher plasma Cys
concentrations in SAA-supplemented mice. However, plasma
CySS does not increase in response to LPS suggesting the
additional effects on ROS homeostasis due to SAA supplemen-
tation. The more reduced redox potential of the Cys/CySS couple
in SAA-supplemented mice is associated with a significant
decrease in circulating and tissue levels of IL-1b and TNF-a.
These data suggest that Cys and associated Cys redox potential are
critical determinants of cytokine production during activation of
the immune system by LPS in mice. Thus, preservation of Eh Cys/
CySS by SAA supplementation may be involved in decreased IL-
Table 3. Mixed model of redox parameters and IL-1b and
TNF-a controlling for time of day.
Biomarker Regression coefficients P
IL-1b SE
Cys, mM 20.19 0.09 ,0.05
CySS, mM 0.28 0.44 ns
EhCys/CySS, mV 1.08 0.28 ,0.001
TNF-a SE
Cys, mM 20.06 0.04 ns
CySS, mM 0.41 0.17 ,0.05
EhCys/CySS, mV 0.25 0.11 ,0.05
doi:10.1371/journal.pone.0005017.t003
Figure 4. Effect of dietary SAA-supplementation on endotoxin-
induced IL-1b and TNF-a. C57BL/6J mice receiving either SAA-
adequate diet or SAA-supplemented diet were treated with 1 mg/kg i.p
endotoxin/LPS. At 2 h, mice were sacrificed and plasma and lung
samples were collected for analysis of IL-1b and TNF-a. Plasma IL-1b
levels are shown in (A). IL-1b levels in lung homogenate are presented
after normalization for total protein (B). In (C) RNA was extracted from
whole lung and transcript levels of IL-1b were quantified by
quantitative real-time PCR. Plasma TNF-a (D) and lung TNF-a (E) were
also determined. Data are mean+SE of 4 replicates of a representative
experiment repeated 2 times, * P,0.05.
doi:10.1371/journal.pone.0005017.g004
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however, that the effects of SAA supplementation may also include
preservation of intracellular thiol/disulfide redox status.
In human nutrition, Cys is a conditionally essential amino acid
because Cys requirements are normally met by the transulfuration
of dietary methionine [38]. However, Cys requirements increase
during infection, injury, and in conditions associated with limited
hepatic transulfuration [39,40]. Because Cys is not routinely added
to solutions used in parenteral therapy, patients with sepsis could be
particularly susceptible to a deficiency of Cys. Studies in humans
have shown that plasma Cys redox potential is modulated fairly
rapidly by precursor availability [26]. Furthermore, in the present
study we find that plasma Cys in humans in negatively associated
with plasma IL-1b levels. Thus, nutritional supplementation with
Cys or Cys precursors during early sepsis may be a strategy to
alleviate acute inflammation and associated tissue injury.
In addition to the pathology associated with disregulated
cytokine production in conditions such as sepsis; elevated cytokine
levels in healthy individuals independently predict risk of chronic
diseases such as type II diabetes and atherosclerosis [41,42].
Therefore, the association between oxidized Eh Cys/CySS and IL-
1b and TNF-a in otherwise healthy individuals suggests that
oxidized Eh Cys/CySS may represent a risk factor for chronic
inflammatory diseases. Accordingly, maintenance of Cys redox
potential may be critical in protecting against subclinical
inflammation in healthy individuals, and in ameliorating patho-
logical processes associated with chronic inflammation. Large
population studies with detailed measurements of known factors
affecting redox potential along with pro-inflammatory cytokine
markers and disease risk factors are needed to test this concept.
Such data are critical because assays are available to assess plasma
Cys redox potential in humans [22,43], and simple and
inexpensive interventional strategies are available which could
improve Cys redox potential [9,44].
The association between oxidative stress and inflammation is
well-recognized and multiple studies have shown that antioxidants
such N-acetyl cysteine, have anti-inflammatory effects. The
present observations identify a mechanistic link between oxidative
stress and inflammation. The combined in vitro and in vivo
observations show that oxidized extracellular Eh Cys/CySS is a
previously unrecognized modulator of IL-1b. The findings suggest
that strategies to preserve Eh Cys/CySS may represent a means to
control IL-1b in inflammatory disease states.
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Figure 5. IL-1b and TNF-a in plasma of healthy adults is increased in association with oxidized Eh Cys/CySS. A linear mixed model was
used to model variation in plasma Eh Cys/CySS and IL-1b and TNF-a. A strong positive association was observed between Eh Cys/CySS and IL-1b (A;
P,0.001). Plasma Cys was negatively associated with IL-1b (B; P,0.05). TNF-a was positively correlated with Eh Cys/CySS (C), and CySS (D) (P,0.05).
doi:10.1371/journal.pone.0005017.g005
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